Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edward Cheng

Orthopaedic Surgery Minneapolis, MN Medical Doctor

NPI 1447287610 CMS profile 246885

University Of Minnesota Physicians, 2512 South 7Th Street, First Floor, R102, Minneapolis, MN 55454

Open in the dashboard

General payments

$57,482

147 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edward Cheng of Minneapolis, MN is reported in the CMS Open Payments database as having received $57,482 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,191 3
2024 General $1,472 5
2023 General $850 2
2022 General $11,789 71
2021 General $3,077 21
2020 General $13,905 4
2019 General $7,199 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edward Cheng
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Edward Cheng were reported at $19,191. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Edward Cheng Orthopaedic Surgery median Middle half National median
2019 $7,199 $644 $140–$2,844 $163
2020 $13,905 $312 $75–$1,860 $114
2021 $3,077 $520 $117–$2,495 $132
2022 $11,789 $598 $128–$2,731 $149
2023 $850 $461 $128–$2,264 $160
2024 $1,472 $497 $134–$2,475 $164
2025 $19,191 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Biotronik Inc. $20,253 106 payments
  2. Ethicon Inc. $18,000 1 payment
  3. Daiichi Sankyo Inc. $13,044 9 payments
  4. Medical Device Business Services, Inc. $2,143 5 payments
  5. Abbott Laboratories $1,908 11 payments
  6. Musculoskeletal Transplant Foundation Inc. $1,044 2 payments
  7. Zimmer Biomet Holdings, Inc. $748 8 payments
  8. Biosense Webster, Inc. $275 2 payments
  9. Stryker Corporation $44 2 payments
  10. DePuy Synthes Sales Inc. $23 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $20,791 46 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,000 1 payment
  3. Honoraria $11,790 2 payments
  4. Food and Beverage $4,804 89 payments
  5. Consulting Fee $1,169 1 payment
  6. Education $929 8 payments
Products named General payments · program years 2019–2025
  1. Turalio $13,044 9 payments
  2. BioMonitor $5,835 40 payments
  3. Solia $4,809 21 payments
  4. Acticor 7 VR-T DX $3,212 16 payments
  5. Rivacor 7 DR-T $3,156 11 payments
  6. Edora 8 DR-T $3,027 8 payments
  7. Rivacor $2,925 20 payments
  8. Edora $2,925 20 payments
  9. Acticor $2,925 20 payments
  10. Carto 3 $2,418 7 payments
  11. Other $4,464 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

93

Median for Orthopedic Surgery: 203

Drug cost

$288

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clindamycin Hcl Generic 19 $162
Amoxicillin Generic 74 $126

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$62,734

Medicare's payments for the services billed

Medicare patients

149

Average age 69

Services billed

328

91 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 70%
High blood pressure 62%
Depression 38%
Diabetes 29%
Chronic kidney disease 26%
Cancer 24%
Ischemic heart disease 19%
Heart failure 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record